Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1996
12/19/1996WO1996040904A1 Secretion leader trap cloning method
12/19/1996WO1996040903A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996WO1996040902A1 Nucleic acid repair enzyme methods for point mutation detection and in vitro mutagenesis
12/19/1996WO1996040901A1 Template and primer based synthesis of enzymatically cleavable oligonucleotides
12/19/1996WO1996040900A1 Materials and methods for the polymerase chain reaction
12/19/1996WO1996040899A1 Materials and methods for digesting dna or rna using restriction endonucleases
12/19/1996WO1996040898A1 Triple-helix forming oligonucleotides for targeted mutagenesis
12/19/1996WO1996040897A2 Chondroitinase i and chondroitinase ii producing mutants of p. vulgaris
12/19/1996WO1996040896A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models
12/19/1996WO1996040895A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models
12/19/1996WO1996040894A1 Treatment of insulin resistance
12/19/1996WO1996040892A1 Tetracycline regulated transcriptional modulators with altered dna binding specificities
12/19/1996WO1996040891A1 Device 'biotron-tszyan i' for transmitting a natural information flow to a biological object
12/19/1996WO1996040885A2 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION
12/19/1996WO1996040884A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996WO1996040882A1 Artificial restriction endonuclease
12/19/1996WO1996040881A1 Fucosyltransferase genes and uses thereof
12/19/1996WO1996040880A1 Recombinant fowlpox viruses and uses thereof
12/19/1996WO1996040879A1 Dna cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same
12/19/1996WO1996040878A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
12/19/1996WO1996040877A1 Immortalization and disimmortalization of cells
12/19/1996WO1996040868A1 Essential oligonucleotides of vertebrate telomerase
12/19/1996WO1996040867A1 Recombinant viral nucleic acids
12/19/1996WO1996040865A1 Replacement therapy for dental caries
12/19/1996WO1996040789A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES
12/19/1996WO1996040788A1 Anti-allergy bispecific molecules
12/19/1996WO1996040776A1 Methods for purifying authentic igf from yeast hosts
12/19/1996WO1996040775A1 Method for the treatment of corticosteroid induced osteopenia
12/19/1996WO1996040771A1 SINGLE CHAIN ANALOGS OF THE TGF-β SUPERFAMILY (MORPHONS)
12/19/1996WO1996040769A1 Developmentally-regulated endothelial cell locus-1
12/19/1996WO1996040768A2 Anti-fungal and anti-bacterial histatin-based peptides
12/19/1996WO1996040766A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
12/19/1996WO1996040762A1 Monocyte chemotactic protein-4
12/19/1996WO1996040736A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding
12/19/1996WO1996040725A1 Phosphonic acid-based cationic lipids
12/19/1996WO1996040724A1 Recombinational cloning using engineered recombination sites
12/19/1996WO1996040723A1 Catalytic dna
12/19/1996WO1996040722A1 Chromosomal expression of heterologous genes in bacterial cells
12/19/1996WO1996040721A1 A cytotoxicity-based genetic selection system (toxsel)
12/19/1996WO1996040719A1 Endothelial-monocyte activating polypeptide iii
12/19/1996WO1996040718A1 Expression of lipoproteins
12/19/1996WO1996040717A1 High-affinity nucleic acid ligands of cytokines
12/19/1996WO1996040715A1 Therapeutic oligonucleotides targeting the human mdr1 and mrp genes
12/19/1996WO1996040714A1 GLYCINE AND PHASEOLUS α-D-GALACTOSIDASES
12/19/1996WO1996040712A1 Nucleic acid mediated electron transfer
12/19/1996WO1996040711A1 Cross-linking oligonucleotides
12/19/1996WO1996040710A1 Triplex-forming antisense oligonucleotides having abasic linkers targeting nucleic acids comprising mixed sequences of purines and pyrimidines
12/19/1996WO1996040709A1 Pna-dna chimeras and pna synthons for their preparation
12/19/1996WO1996040703A1 High affinity nucleic acid ligands to lectins
12/19/1996WO1996040627A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/19/1996WO1996040290A1 Immunological combination compositions and methods
12/19/1996WO1996040284A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996WO1996040272A1 Aav transduction of myoblasts
12/19/1996WO1996040271A1 Treatment of hemoglobinopathies
12/19/1996WO1996040270A1 In vitro packaging of adeno-associated virus dna
12/19/1996WO1996040269A1 INCREASING rAAV TITER
12/19/1996WO1996040268A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996WO1996040267A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996WO1996040266A1 Method of treatment for asthma
12/19/1996WO1996040264A1 Separation of active complexes
12/19/1996WO1996040260A2 Immunotoxins specific for cd80 and cd86 expressing cells
12/19/1996WO1996040253A2 Rna photocleavage using texaphyrins
12/19/1996WO1996040252A1 High affinity human monoclonal antibodies specific for rsv f-protein
12/19/1996WO1996040241A1 Recombinant poxvirus-rabies compositions and combination compositions and uses
12/19/1996WO1996040240A1 Helper virus-free aav production
12/19/1996WO1996040238A1 Vectors for the diagnosis and treatment of solid tumors including melanoma
12/19/1996WO1996040231A1 Method for obtaining receptor agonist antibodies
12/19/1996WO1996040229A1 Vaccines synthesized by transgenic plants
12/19/1996WO1996040219A1 Inhibin compositions and methods of enhancing production performance
12/19/1996WO1996040210A1 Antibody and antibody fragments for inhibiting the growth of tumors
12/19/1996WO1996040209A1 Method for identifying or isolating a molecule and molecules identified thereby
12/19/1996WO1996040199A1 Methods of inhibiting phagocytosis
12/19/1996WO1996040197A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
12/19/1996WO1996040196A1 Appetite regulating compositions
12/19/1996WO1996040195A1 Gene therapy for myocardial ischemia
12/19/1996WO1996040186A1 Relaxin-like factor and methods and uses thereof
12/19/1996WO1996040173A1 Hapten modified tumor cell extract and methods of treating or screening for cancer
12/19/1996WO1996040162A1 Method of treatment for lung diseases using antisense oligonucleotides
12/19/1996WO1996040159A1 Capped synthetic rna, analogs, and aptamers
12/19/1996WO1996040157A1 USE OF ANTISENSE OLIGONUCLEOTIDES TO IL-6 RECEPTOR mRNA TO INHIBIT CELLULAR PROLIFERATION
12/19/1996WO1996040067A1 Cationic lipid acid salt of 3 beta [n-(n',n'-dimethylaminoethane)-carbamoyl] cholesterol
12/19/1996WO1996040062A1 A method of transfection of cells using liposomally encapsulated nucleic acids
12/19/1996WO1996040040A2 Thrombin receptor homolog
12/19/1996WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
12/19/1996WO1996039843A1 Controlling hemipteran insect pests with bacillus thuringiensis
12/19/1996WO1996039841A1 Tumor- or cell-specific herpes simplex virus replication
12/19/1996WO1996039827A1 Repellent compositions containing flavonoid aldehydes
12/19/1996WO1996039806A1 Transgenic plants co-expressing a functional human 2-5a system
12/19/1996WO1996039805A1 Plant glutamate receptors
12/19/1996WO1996039803A1 Use of the indeterminate gametophyte gene for maize improvement
12/19/1996WO1996039802A1 Hypersensitive response induced resistance in plants
12/19/1996WO1996036722A3 Embedded expression of heterologous proteins
12/19/1996DE19521705A1 Immunogenes Konstrukt, Verfahren zu dessen Herstellung und Verwendung als Vakzine An immunogenic construct, a process for its preparation and use as a vaccine
12/19/1996DE19521412A1 Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung New cationic and polycationic amphiphiles containing these reagents and their use
12/19/1996DE19521314A1 Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid Adhärenzgen from Helicobacter pylori and it polypeptide encoded
12/19/1996DE19521312A1 Verfahren zur Identifizierung sekretorischer Gene aus Helicobacter pylori A method for identifying secretory genes from Helicobacter pylori
12/19/1996CA2787069A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2786782A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2704354A1 Expression of lipoproteins
12/19/1996CA2332731A1 Oligonucleotide tags for sorting and identification
1 ... 3661 3662 3663 3664 3665 3666 3667 3668 3669 3670 3671 3672 3673 3674 3675 3676 3677 3678 3679 3680 3681 ... 4023